Alimera Sciences (ALIM) Reports Smaller-Than-Expected Loss; Comments on Outlook
Tweet Send to a Friend
Alimera Sciences, Inc. (Nasdaq: ALIM) reports a Q2 loss of $0.20, 6 cents better than the analyst estimate of ($0.26).
This article: 158 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 158 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
